Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Curtius Rearrangement. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108101857B details a high-yield route for 2-amino-3-bromo-6-chloropyrazine, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Curtius rearrangement method for 4-amino-2,6-dichloropyridine. High purity, avoids explosive azides. Ideal for API manufacturing.
Patent CN1168883A reveals a novel 3-stage synthesis for high-purity cyclopentane-beta-amino acids, offering superior enantioselectivity and streamlined manufacturing for global supply chains.
Patent CN1049656A discloses novel lipoxygenase inhibitors. Efficient synthesis via sulfonyl isocyanate coupling offers cost-effective API intermediate manufacturing solutions.
Novel preparation method for Raltitrexed degradation impurity ensures high purity and supply stability for pharmaceutical quality research and regulatory compliance.
Patent CN101880241A reveals a safer one-pot Curtius rearrangement for Candesartan intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN102249929A reveals a safer DPPA-based route for Ticagrelor intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN1317481A details a scalable synthetic route for 4,5-diamino shikimic acid derivatives from isophthalic acid, offering significant cost reduction and supply stability for neuraminidase inhibitor manufacturing.
Patent CN114920670B reveals a novel two-step synthesis for 5-chloro-2-aminobenzenesulfonamide, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103073443B details a novel asymmetric synthesis for Pregabalin, offering improved yield and scalability for pharmaceutical supply chains.
Advanced asymmetric synthesis of pregabalin via CN103073443B. Offers cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain solutions.
Novel cyclization process for thienopyrrole derivatives avoiding explosive hazards. Enhanced safety and scalability for glycogen phosphorylase inhibitor production.
Novel route for 3-amino-7-chloroquinoline via Curtius rearrangement offers high yield and scalable production for antimalarial drug intermediates.
Novel Curtius rearrangement method ensures safe, scalable production of 1-aryl-2-acetone compounds for global pharmaceutical supply chains.
Patent CN100473642C details a 4-step asymmetric synthesis of alpha-alkyl-isoserine with 98% ee. Offers cost-effective routes for pharmaceutical intermediates.
Novel synthesis route for chiral aryl cyclopropyl amine derivatives. Enhances yield and scalability for Ticagrelor intermediate production. Reliable supply chain partner.
Patent CN110903245A reveals a novel route for 1-alkyl-2-trifluoromethyl-5-amino-1H-imidazole intermediates, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN108912032A details an efficient seven-step synthesis for chiral pyrrolidine derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Curtius rearrangement route for pyrrolo[1,2-A]quinoxalin-4(5H)-one. High purity, scalable pharma intermediate synthesis avoiding toxic reagents.